J. Wai-kuoshihandjohn L. Gerin
#131,849
Most Influential Person Now
J. Wai-kuoshihandjohn L. Gerin's AcademicInfluence.com Rankings
J. Wai-kuoshihandjohn L. Gerinphilosophy Degrees
Philosophy
#6432
World Rank
#9467
Historical Rank
Logic
#3599
World Rank
#4787
Historical Rank
J. Wai-kuoshihandjohn L. Gerinbiology Degrees
Biology
#8766
World Rank
#11895
Historical Rank
Virology
#193
World Rank
#199
Historical Rank
Molecular Biology
#1138
World Rank
#1164
Historical Rank
Biochemistry
#1293
World Rank
#1412
Historical Rank
Download Badge
Philosophy Biology
J. Wai-kuoshihandjohn L. Gerin's Degrees
- PhD Biochemistry University of California, Berkeley
- Doctorate Medicine Stanford University
Why Is J. Wai-kuoshihandjohn L. Gerin Influential?
(Suggest an Edit or Addition)J. Wai-kuoshihandjohn L. Gerin's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- DNA Polymerase Associated with Human Hepatitis B Antigen (1973) (692)
- Structure, sequence and expression of the hepatitis delta (δ) viral genome (1986) (541)
- Transmission of the hepatitis B virus-associated delta antigen to chimpanzees. (1980) (466)
- delta Agent: association of delta antigen with hepatitis B surface antigen and RNA in serum of delta-infected chimpanzees. (1980) (381)
- The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks (1993) (371)
- Type B hepatitis: the infectivity of blood positive for e antigen and DNA polymerase after accidental needlestick exposure. (1976) (367)
- Structure and replication of the genome of hepatitis delta virus. (1986) (291)
- Hepatitis B virus DNA in the sera of HBsAg carriers: A marker of active hepatitis B virus replication in the liver (1981) (287)
- An assay for the detection of the dna genome of hepatitis b virus in serum (1982) (276)
- Type B hepatitis after needle-stick exposure: prevention with hepatitis B immune globulin. Final report of the Veterans Administration Cooperative Study. (1978) (275)
- Natural history of acute hepatitis B surface antigen-positive hepatitis in Greek adults. (1987) (270)
- A genotype of hepatitis D virus that occurs in northern South America. (1993) (266)
- Hepatocarcinogenicity of the woodchuck hepatitis virus. (1987) (261)
- Molecular cloning of hepatitis delta virus RNA from an infected woodchuck liver: sequence, structure, and applications (1988) (260)
- Live recombinant vaccinia virus protects chimpanzees against hepatitis B (1984) (254)
- EPIDEMIOLOGY OF HBV-ASSOCIATED DELTA AGENT: GEOGRAPHICAL DISTRIBUTION OF ANTI-DELTA AND PREVALENCE IN POLYTRANSFUSED HBsAg CARRIERS (1980) (225)
- A single antigenomic open reading frame of the hepatitis delta virus encodes the epitope(s) of both hepatitis delta antigen polypeptides p24 delta and p27 delta (1988) (222)
- DNA vaccine for hepatitis B: evidence for immunogenicity in chimpanzees and comparison with other vaccines. (1996) (217)
- Successful passive and active immunization of cynomolgus monkeys against hepatitis E. (1994) (211)
- Induction of partial immunity to influenza by a neuraminidase-specific vaccine. (1974) (209)
- Use of a standardized cell culture assay to assess activities of nucleoside analogs against hepatitis B virus replication. (1992) (192)
- Hepatitis D virus RNA editing: specific modification of adenosine in the antigenomic RNA (1995) (190)
- Hepatitis B virus (HBV)/hepatitis D virus (HDV) coinfection in outbreaks of acute hepatitis in the Peruvian Amazon basin: the roles of HDV genotype III and HBV genotype F. (1996) (186)
- The hepatitis B virus-associated delta antigen: isolation from liver, development of solid-phase radioimmunoassays for delta antigen and anti-delta and partial characterization of delta antigen. (1980) (183)
- INCIDENCE AND SIGNIFICANCE OF ANTIBODIES TO DELTA ANTIGEN IN HEPATITIS B VIRUS INFECTION (1979) (170)
- Antigens of hepatitis delta virus in the liver and serum of humans and animals. (1986) (167)
- Woodchuck hepatitis and hepatocellular carcinoma: Correlation of histologic with virologic observations (1981) (151)
- Transmission of the hepatitis B virus-associated delta agent to the eastern woodchuck. (1984) (150)
- Hepatitis B subunit vaccine: a preliminary report of safety and efficacy tests in chimpanzees. (1975) (148)
- Recombinant vaccine against hepatitis E: dose response and protection against heterologous challenge. (1997) (145)
- Native hepatitis B virions and capsids visualized by electron cryomicroscopy. (2006) (140)
- Viral hepatitis, type B, DNA polymerase activity and antibody to hepatitis B core antigen. (1974) (139)
- Hepatocellular carcinoma in the woodchuck model of hepatitis B virus infection. (2004) (138)
- Hepatocellular carcinoma in woodchuck hepatitis virus‐infected woodchucks: Presence of viral DNA in tumor tissue from chronic carriers and animals serologically recovered from acute infections (1989) (136)
- Antiviral activity of clevudine [L‐FMAU, (1‐(2‐fluoro‐5‐methyl‐β, L‐arabinofuranosyl) uracil)] against woodchuck hepatitis virus replication and gene expression in chronically infected woodchucks (Marmota monax) (2001) (135)
- Structural requirements for RNA editing in hepatitis delta virus: evidence for a uridine-to-cytidine editing mechanism. (1992) (135)
- The precore gene of the woodchuck hepatitis virus genome is not essential for viral replication in the natural host (1992) (134)
- Expression of the hepatitis B virus surface antigen gene in cell culture by using a simian virus 40 vector. (1981) (134)
- Transmission of hepatitis B to chimpanzees by hepatitis B surface antigen-positive saliva and semen (1977) (130)
- Structure, sequence and expression of the hepatitis delta (delta) viral genome. (1986) (127)
- Hepadnavirus infection of peripheral blood lymphocytes in vivo: woodchuck and chimpanzee models of viral hepatitis (1986) (122)
- Delta hepatitis agent: structural and antigenic properties of the delta-associated particle (1984) (120)
- The woodchuck model of hepatitis B virus infection. (2001) (117)
- Replication of human hepatitis delta virus in primary cultures of woodchuck hepatocytes (1987) (117)
- Hepatitis B virus infection in the acquired immunodeficiency syndrome. (1984) (116)
- Geographic distribution and genetic variability of hepatitis delta virus genotype I. (1997) (113)
- Structure, sequence and expression of the hepatitis delta (δ) viral genome (1987) (112)
- Effects of age and viral determinants on chronicity as an outcome of experimental woodchuck hepatitis virus infection (2000) (110)
- Antiviral activity and toxicity of fialuridine in the woodchuck model of hepatitis B virus infection (1998) (108)
- Biophysical Properties of Australia Antigen (1969) (107)
- Radioimmunoassay for the detection of the core of the Dane particle and antibody to it. (1974) (106)
- Chemically synthesized peptides of hepatitis B surface antigen duplicate the d/y specificities and induce subtype-specific antibodies in chimpanzees. (1983) (104)
- Histologic Studies of Severe Delta Agent Infection in Venezuelan Indians (2007) (102)
- Type D hepatitis: The clinical significance of hepatitis D virus RNA in serum as detected by a hybridization‐based assay (1986) (102)
- Australia Antigen: Large-Scale Purification from Human Serum and Biochemical Studies of Its Proteins (1971) (101)
- Licensed recombinant hepatitis B vaccines protect chimpanzees against infection with the prototype surface gene mutant of hepatitis B virus (1999) (100)
- Immunochemical identification of viral and nonviral proteins of the respiratory syncytial virus virion (1982) (93)
- Demonstration of subpopulations of Dane particles (1976) (91)
- Treatment of chronic woodchuck hepatitis virus infection in the eastern woodchuck (marmota monax) with nucleoside analogues is predictive of therapy for chronic hepatitis B virus infection in humans (2000) (90)
- MODIFICATION OF CHRONIC HEPATITIS-B VIRUS INFECTION IN CHIMPANZEES BY ADMINISTRATION OF AN INTERFERON INDUCER (1976) (89)
- Titration of the infectivity of hepatitis D virus in chimpanzees. (1987) (88)
- Mitogen-induced replication of woodchuck hepatitis virus in cultured peripheral blood lymphocytes. (1988) (87)
- Diagnostic and prognostic significance of the IgM antibody to the hepatitis delta virus. (1986) (84)
- Natural history of woodchuck hepatitis virus infections during the course of experimental viral infection: molecular virologic features of the liver and lymphoid tissues (1989) (83)
- Immunization with Surface Antigen Vaccine Alone and after Treatment with 1-(2-Fluoro-5-Methyl-β-l-Arabinofuranosyl)-Uracil (l-FMAU) Breaks Humoral and Cell-Mediated Immune Tolerance in Chronic Woodchuck Hepatitis Virus Infection (2002) (82)
- Deficiencies in the Acute-Phase Cell-Mediated Immune Response to Viral Antigens Are Associated with Development of Chronic Woodchuck Hepatitis Virus Infection following Neonatal Inoculation (2002) (77)
- Lymphoid cells in the spleens of woodchuck hepatitis virus-infected woodchucks are a site of active viral replication (1987) (77)
- Preclinical investigation of L-FMAU as an anti-hepatitis B virus agent. (1998) (72)
- An ultraviolet-sensitive RNA structural element in a viroid-like domain of the hepatitis delta virus. (1989) (71)
- The δ agent: HBsAg particles with δ antigen and RNA in the serum of an HBV carrier (1981) (69)
- The hepatitis delta virus and its infection (1987) (68)
- An outbreak of fulminant hepatitis delta in the Waorani, an indigenous people of the Amazon basin of Ecuador. (2000) (68)
- Immunogenicity and protective efficacy of a vaccine prepared from 53 kDa truncated hepatitis E virus capsid protein expressed in insect cells. (2001) (67)
- Pathogenesis of experimental neonatal woodchuck hepatitis virus infection: Chronicity as an outcome of infection is associated with a diminished acute hepatitis that is temporally deficient for the expression of interferon gamma and tumor necrosis factor‐alpha messenger RNAs (2001) (66)
- Recombinant vaccine against hepatitis E: duration of protective immunity in rhesus macaques. (2002) (66)
- Inactivated whole-virus vaccine derived from a proviral DNA clone of simian immunodeficiency virus induces high levels of neutralizing antibodies and confers protection against heterologous challenge. (1992) (65)
- Biochemical characterization of Australia antigen. Evidence for defective particles of hepatitis B virus. (1975) (64)
- Advances in hepatitis D virus biology and disease. (1994) (64)
- Cloned fragment of the hepatitis delta virus RNA genome: sequence and diagnostic application. (1986) (63)
- Woodchuck hepatitis virus surface antigen induces nitric oxide synthesis in hepatocytes: possible role in hepatocarcinogenesis. (1994) (62)
- Type B hepatitis: a review of current prospects for a safe and effective vaccine. (1980) (62)
- Core antigen and antibody in woodchucks after infection with woodchuck hepatitis virus (1984) (62)
- Hepatitis delta virus (HDV) and woodchuck hepatitis virus (WHV) nucleic acids in tissues of HDV-infected chronic WHV carrier woodchucks (1989) (61)
- New enzyme immunoassays for the serologic detection of woodchuck hepatitis virus infection. (1993) (61)
- Evidence for replication of hepatitis delta virus RNA in hepatocyte nuclei after in vivo infection. (1988) (61)
- Hepatitis D viremia following orthotopic liver transplantation involves a typical HDV virion with a hepatitis B surface antigen envelope (1998) (61)
- Depletion of mitochondrial DNA, destruction of mitochondria, and accumulation of lipid droplets result from fialuridine treatment in woodchucks (Marmota monax). (1997) (59)
- Complete nucleotide sequence of a molecular clone of woodchuck hepatitis virus that is infectious in the natural host. (1989) (58)
- Hepatitis delta virus disease. (1986) (58)
- Effect of Oral Administration of Emtricitabine on Woodchuck Hepatitis Virus Replication in Chronically Infected Woodchucks (2000) (56)
- Genotype-Specific Complementation of Hepatitis Delta Virus RNA Replication by Hepatitis Delta Antigen (1998) (56)
- Hepatitis B-specific DNA polymerase activity during post-transfusion hepatitis (1974) (56)
- Biophysical characterization of the adr subtype of hepatitis B antigen and preparation of anti-r sera in rabbits. (1975) (55)
- Viral hepatitis in Colombia: A study of the “hepatitis of the Sierra Nevada de Santa Marta” (1985) (55)
- Hepatitis B Markers in United States Drug Addicts with Special Emphasis on the Delta Hepatitis Virus (1984) (55)
- Integration of woodchuck hepatitis and N‐myc rearrangement determine size and histologic grade of hepatic tumors (2004) (54)
- The Development of Balb/c Cells Persistently Infected with Respiratory Syncytial Virus: Presence of Ribonucleoprotein on the Cell Surface 1 (1981) (53)
- Temporal pathogenesis of experimental neonatal woodchuck hepatitis virus infection: Increased initial viral load and decreased severity of acute hepatitis during the development of chronic viral infection (2000) (53)
- Cyclosporin A modulates the course of woodchuck hepatitis virus infection and induces chronicity. (1991) (52)
- Clevudine Therapy with Vaccine Inhibits Progression of Chronic Hepatitis and Delays Onset of Hepatocellular Carcinoma in Chronic Woodchuck Hepatitis Virus Infection (2004) (51)
- A human monoclonal antibody that recognizes viral polypeptides and in vitro translation products of the genome of the hepatitis D virus. (1987) (51)
- Sequence comparison of woodchuck hepatitis virus replicative forms shows conservation of the genome. (1988) (50)
- Chronic hepatitis D virus (HDV) infection in hepatitis B virus carrier chimpanzees experimentally superinfected with HDV. (1988) (48)
- Natural and experimental infection of woodchucks with woodchuck hepatitis virus, as measured by new, specific assays for woodchuck surface antigen and antibody (1982) (48)
- Antisense oligonucleotides are effective inhibitors of hepatitis B virus replication in vitro. (1995) (48)
- Proteins of hepatitis B surface antigen (1977) (47)
- Systemic distribution of woodchuck hepatitis virus in the tissues of experimentally infected woodchucks. (1988) (46)
- The stabilization and purification of respiratory syncytial virus using MgSO4. (1980) (45)
- Non-specificity of anti-HCV test for seroepidemiological analysis (1990) (45)
- Immunogenic Effects of Woodchuck Hepatitis Virus Surface Antigen Vaccine in Combination with Antiviral Therapy: Breaking of Humoral and Cellular Immune Tolerance in Chronic Woodchuck Hepatitis Virus Infection (2003) (43)
- Cytoplasmic Tubular Structures in Liver of HBsAg Carrier Chimpanzees Infected with Delta Agent and Comparison with Cytoplasmic Structures in Non‐A, Non‐B Hepatitis (2007) (43)
- Antiviral Activities of Oral 1-O-Hexadecylpropanediol-3-Phosphoacyclovir and Acyclovir in Woodchucks with Chronic Woodchuck Hepatitis Virus Infection (2000) (43)
- Kinetics of synthesis of respiratory syncytial virus glycoproteins. (1985) (43)
- Adenine arabinoside 5′‐monophosphate treatment of chronic type B hepatitis (1982) (42)
- Classification of Hybridomas to Respiratory Syncytial Virus Glycoproteins (1982) (42)
- Preparation and characterization of complement-fixing hepatitis-associated antigen and antiserum. (1970) (41)
- The woodchuck animal model of hepatitis B-like virus infection and disease. (1983) (41)
- Global Screening for Human Viral Pathogens (2003) (41)
- Structure and replication of the genome of the hepatitis delta virus. (1986) (39)
- Monoclonal antibodies to respiratory syncytial virus: detection of virus neutralization and other antigen-antibody systems using infected human and murine cells. (1981) (39)
- Hepadnavirus-induced liver cancer in woodchucks. (1989) (39)
- Buoyant Density of the Hepatitis A Virus-Like Particle in Cesium Chloride (1974) (39)
- Double infections with hepatitis A and B viruses. (2008) (38)
- Antigenic analysis of woodchuck hepatitis virus surface antigen with site-specific radioimmunoassays (1984) (38)
- Enhanced Antiviral Benefit of Combination Therapy with Lamivudine and Alpha Interferon against WHV Replication in Chronic Carrier Woodchucks (1999) (38)
- Antigenicity of the major polypeptides of hepatitis B surface antigen (HBsAg). (1978) (38)
- Identification of HBV DNA sequences that are predictive of response to lamivudine therapy (2004) (38)
- The Size of the Hepatitis Delta Agent (1989) (37)
- Clevudine Inhibits Hepatitis Delta Virus Viremia: a Pilot Study of Chronically Infected Woodchucks (2005) (36)
- Immunochemistry of hepatitis B surface antigen (HBsAg): preparation and characterization of antibodies to the constituent polypeptides. (1975) (36)
- Antiviral Effects of Lamivudine, Emtricitabine, Adefovir Dipivoxil, and Tenofovir Disoproxil Fumarate Administered Orally Alone and in Combination to Woodchucks with Chronic Woodchuck Hepatitis Virus Infection (2008) (36)
- Serial passage of hepatitis delta virus in chronic hepatitis B virus carrier chimpanzees (1988) (36)
- Activation of human peripheral blood B cells following immunization with hepatitis B surface antigen vaccine. (1984) (36)
- Liver‐targeted antiviral nucleosides: Enhanced antiviral activity of phosphatidyl‐dideoxyguanosine versus dideoxyguanosine in woodchuck hepatitis virus infection in vivo (1996) (35)
- Role of type 1 versus type 2 immune responses in liver during the onset of chronic woodchuck hepatitis virus infection (2003) (35)
- Enhanced antiviral benefit of combination therapy with lamivudine and famciclovir against WHV replication in chronic WHV carrier woodchucks. (2000) (35)
- Hepatic expression of the woodchuck hepatitis virus X‐antigen during acute and chronic infection and detection of a woodchuck hepatitis virus X‐antigen antibody response (1997) (35)
- Protection of chimpanzees from type B hepatitis by immunization with woodchuck hepatitis virus surface antigen (1986) (34)
- In vitro activation of woodchuck lymphocytes measured by radiopurine incorporation and interleukin‐2 production: Implications for modeling immunity and therapy in hepatitis B virus infection (1995) (34)
- Evidence against a requisite role for defective virus in the establishment of persistent hepadnavirus infections. (1990) (33)
- Immunochemistry and polypeptide composition of hepatitis B core antigen (HBc Ag). (1977) (32)
- Immunosuppression with cyclosporine during the incubation period of experimental woodchuck hepatitis virus infection increases the frequency of chronic infection in adult woodchucks. (1992) (32)
- Epidemiology of the delta agent: an introduction. (1983) (32)
- Expression of hepatitis B virus-specific markers in asymptomatic hepatitis B surface antigen carriers (1977) (31)
- Hepatitis B virus, hepatitis non‐A, non‐B virus and hepatitis delta virus in lyophilized antihemophilic factor: Relative sensitivity to heat (1985) (31)
- Human immunodeficiency virus and hepatitis delta virus in homosexual men. A study of four cohorts. (1988) (31)
- Antiviral Effect of Oral Administration of Tenofovir Disoproxil Fumarate in Woodchucks with Chronic Woodchuck Hepatitis Virus Infection (2005) (31)
- A radioimmunoassay for HBcAg in the sera of HBsAg carriers: Serum HBcAg, serum DNA polymerase activity, and liver HBcAg immunofluorescence as markers of chronic liver disease (1981) (30)
- Experimental transmission of the delta agent to chimpanzees. (1983) (30)
- Suppression of lamivudine-resistant B-domain mutants by adefovir dipivoxil in the woodchuck hepatitis virus model. (2004) (30)
- Hepatocellular carcinoma in Richardson's ground squirrels (Spermophilus richardsonii): Evidence for association with hepatitis B–like virus infection (1991) (29)
- Production of monoclonal antibodies against hepatitis B surface antigen (HBsAg) by somatic cell hybrids. (1980) (29)
- Hepatitis B vaccines. On the threshold. (1978) (29)
- Inactivated whole SIV vaccine in macaques: evaluation of protective efficacy against challenge with cell-free virus or infected cells. (1992) (28)
- Radioimmunoassay and characterization of woodchuck hepatitis virus core antigen and antibody. (1985) (28)
- Purification of Influenza Virus in the K-II Zonal Centrifuge (1969) (28)
- Enzyme-linked immunosorbent assay for detection of antibody to the hepatitis B surface antigen-associated delta antigen (1981) (28)
- Basis of hepatitis delta virus disease? (1989) (28)
- Intrahepatic markers of hepatitis delta virus infection: a study by in situ hybridization. (1989) (28)
- Hepatitis delta antigen. Antigenic structure and humoral immune response. (1989) (27)
- Experimental hepatitis delta virus infection in the chimpanzee. (1987) (27)
- Reappearance of hepatitis D virus (HDV) replication in chronic hepatitis B virus carrier chimpanzees rechallenged with HDV. (1989) (27)
- Riboprobe assay for HDV RNA: A sensitive method for the detection of the HDV genome in clinical serum samples (1990) (26)
- Proteins of hepatitis B surface antigen: amino acid compositions of the major polypeptides (1977) (25)
- Chemoimmunotherapy of Chronic Hepatitis B Virus Infection in the Woodchuck Model Overcomes Immunologic Tolerance and Restores T-Cell Responses to Pre-S and S Regions of the Viral Envelope Protein (2007) (25)
- Attempts to transmit hepatitis B virus to chimpanzees by arthropods. (1991) (24)
- Intrahepatic markers of hepatitis delta virus infection: A study by in Situ hybridization (1989) (24)
- Hepatitis delta virus infection of the liver. (1984) (24)
- Apparent helper-independent infection of woodchucks by hepatitis delta virus and subsequent rescue with woodchuck hepatitis virus (1994) (24)
- Immunosuppression reactivates viral replication long after resolution of woodchuck hepatitis virus infection (2007) (24)
- Characterization of antibodies to the structural polypeptides of HGSAg: evidence for subtype-specific determinants. (1976) (24)
- In vitro antigen-induced antibody responses to hepatitis B surface antigen in man. Kinetic and cellular requirements. (1984) (23)
- Mutations in the conserved woodchuck hepatitis virus polymerase FLLA and YMDD regions conferring resistance to lamivudine. (2002) (23)
- A preliminary report of a controlled study of thymosin alpha-1 in the woodchuck model of hepadnavirus infection. (1992) (23)
- Cell-mediated immunity to hepatitis B surface antigen in man. (1984) (22)
- Relationship of large hepatitis B surface antigen polypeptide to human serum albumin (1980) (22)
- The delta agent: HBsAg particles with delta antigen and RNA in the serum of an HBV carrier. (1981) (21)
- The Ausria test: critical evaluation of sensitivity and specificity. (1973) (21)
- Genetic Changes in Hepatitis Delta Virus from Acutely and Chronically Infected Woodchucks (2006) (21)
- Surface antigenic determinants of mammalian "hepadnaviruses" defined by group- and class-specific monoclonal antibodies (1982) (21)
- Natural history of experimental woodchuck hepatitis virus infection: molecular virologic features of the pancreas, kidney, ovary, and testis (1990) (20)
- Prospects for second and third generation hepatitis B vaccines (1985) (20)
- a agent: Association of a antigen with hepatitis B surface antigen and RNA in serum of B-infected chimpanzees (20)
- Kinetics of viremia and acute liver injury in relation to outcome of neonatal woodchuck hepatitis virus infection (2004) (20)
- Animal models of hepatitis delta virus infection and disease. (2001) (20)
- Further studies by immunofluorescence of the monoclonal antibodies associated with experimental non‐A, non‐B hepatitis in chimpanzees and their relation to D hepatitis (1986) (19)
- Nonoverlapping antigenic sites of woodchuck hepatitis virus surface antigen and their cross-reactivity with ground squirrel hepatitis virus and hepatitis B virus surface antigens (1983) (19)
- Viral hepatitis: biological and clinical features, specific diagnosis, and prophylaxis. Second edition. (1985) (19)
- Frequency and significance of delta antibody in acute and chronic hepatitis B. A United States experience. (1985) (18)
- Experimental HBV and δ infections of chimpanzees: Occurrence and significance of intrahepatic immune complexes of HBcAg and δ antigen (1981) (18)
- Pharmacodynamics of (−)-β-2′,3′-Dideoxy-3′-Thiacytidine in Chronically Virus-Infected Woodchucks Compared to Its Pharmacodynamics in Humans (1998) (17)
- Production of hepatitis B virus by stably transfected monocytic cell line U-937: a model for extrahepatic hepatitis B virus replication. (1992) (17)
- Treatment of chronic hepatitis delta virus (HDV) infection with human lymphoblastoid alpha interferon. (1989) (17)
- Properties of delta-associated ribonucleic acid. (1983) (17)
- Cloning and characterization of partial cDNAs for woodchuck cytokines and CD3ϵ with applications for the detection of RNA expression in tissues by RT‐PCR assay (1997) (17)
- In vitro production of infectious woodchuck hepatitis virus by lipopolysaccharide-stimulated peripheral blood lymphocytes. (1989) (17)
- Expression of hepatitis B virus surface and e antigen genes cloned in bovine papillomavirus vectors. (1984) (16)
- Failure to detect polyalbumin-binding sites on the woodchuck hepatitis virus surface antigen: implications for the pathogenesis of hepatitis B virus in humans (1986) (15)
- The woodchuck model of HDV infection. (2006) (14)
- Immunochemistry of the hepatitis B virus: 125I HB Ag ligand. (1974) (14)
- DOES DELTA AGENT CONTRIBUTE TO FULMINANT HEPATITIS? (1983) (14)
- Immunopathology of glomerulonephritis associated with chronic woodchuck hepatitis virus infection in woodchucks (Marmota monax). (1992) (14)
- Real-time polymerase chain reaction assays for leukocyte CD and cytokine mRNAs of the Eastern woodchuck (Marmota monax). (2002) (14)
- Safety and immunogenicity of a purified hepatitis B virus vaccine prepared by using recombinant DNA technology. (1987) (14)
- The demonstration of subtype (D or Y)-specific determinants on the surface of the presumed hepatitis B virus. (1977) (14)
- A polymerase-chain reaction-based assay for serum HDV RNA. (1991) (14)
- Characterization of hepatitis B virus (Dane particle). (1980) (13)
- DNA ploidy analysis of hepatic preneoplastic and neoplastic lesions in woodchucks experimentally infected with woodchuck hepatitis virus (1994) (13)
- Significance of IgM antibody to hepatitis B core antigen in a Greek population with chronic hepatitis B virus infection. (2008) (13)
- Rapid immunity to vaccination with woodchuck hepatitis virus surface antigen using cationic liposome–DNA complexes as adjuvant (2009) (12)
- Biophysical and biochemical characterization of hepatitis B antigen. (1975) (11)
- The Molecular Biology of Hepatitis Delta Virus: Recent Advances (1994) (11)
- A final report on safety and immunogenicity of a bivalent aqueous subunit HBV vaccine (1985) (11)
- Cross‐species hybridization: Characterization of gene expression in woodchuck liver using human membrane arrays (2004) (11)
- Interferon‐γ‐associated responses to woodchuck hepatitis virus infection in neonatal woodchucks and virus‐infected hepatocytes (2004) (10)
- Clinical significance of HDV RNA in HDV disease. (1987) (10)
- Hepatitis delta (δ) cDNA clones: Undetectable hybridization to nucleic acids from infectious non‐A, non‐B hepatitis materials and hepatitis B DNA (1987) (10)
- Effect of Influenza Anti-Neuraminidase Antibody on Virus Neutralization (1973) (10)
- Experimental hepatitis delta virus infection in the animal model. (1991) (10)
- Passive hemagglutination assay for antibody to subtypes of hepatitis B antigen. (1974) (10)
- Antigens of hepatitis B virus: failure to detect HBeAg on the surfaces of HBsAg forms. (1978) (9)
- Antiviral Effect of Orally Administered (−)-β-d-2-Aminopurine Dioxolane in Woodchucks with Chronic Woodchuck Hepatitis Virus Infection (2007) (9)
- In vitro immune responses to hepatitis B surface antigens S and preS2 during acute infection by hepatitis B virus in humans. (1990) (8)
- The viroid-like structure of the hepatitis delta (delta) genome: synthesis of a viral antigen in recombinant bacteria. (1987) (8)
- Buoyant density in cesium chloride of the human reoviruslike agent of infantile gastroenteritis by ultracentrifugation, electron microscopy, and complement fixation. (1976) (8)
- Anti-HBc, HBeAg and DNApolymerase activity in healthy HBsAg carriers and patients with inflammatory liver diseases (1978) (8)
- The Taxonomy of Hepatitis Delta Virus (1994) (8)
- α-Fetoprotein in the Woodchuck Model of Hepadnavirus Infection and Disease: Normal Physiological Patterns and Responses to Woodchuck Hepatitis Virus Infection and Hepatocellular Carcinoma (1990) (8)
- Altered glycosylation of alpha-fetoprotein in hepadnavirus-induced hepatocellular carcinoma of the woodchuck. (1992) (8)
- The novel tertiary structure in delta RNA may function as a ribozyme control element. (1991) (8)
- Modulation of hepatitis delta virus infection by vaccination with synthetic peptides: a preliminary study in the woodchuck model. (1993) (7)
- Out-of-frame versus in-frame core internal deletion variants of human and woodchuck hepatitis B viruses. (2002) (7)
- Antiviral agents for hepatitis B (1991) (7)
- Frequency and significance of delta antibody in acute and chronic hepatitis B (1985) (7)
- International Workshop on Hepatitis B and Liver Cancer: Special Report (1978) (7)
- Determinants of RNA editing in hepatitis delta virus. (1993) (6)
- Experimental HBV and delta infections of chimpanzees: occurrence and significance of intrahepatic immune complexes of HBcAg and delta antigen. (1981) (6)
- α‐fetoprotein in the woodchuck model of hepadnavirus infection and disease: Immunochemical analysis of woodchuck α‐fetoprotein and measurement in serum by quantitative monoclonal radioimmunoassay (1990) (6)
- Expression ofthehepatitis Bvirus surface antigen geneincell culture byusing asimian virus 40vector (1981) (6)
- Relation between non-A, non-B and delta hepatitis: studies with monoclonal antibodies. (1987) (6)
- Characterization of proteins of hepatitis delta virus. (1987) (5)
- Demonstration and partial characterization of 22-nm HBsAg and Dane particles of subtype HBsAg/ady. (1979) (5)
- Hepatitis B virus replication and clinical outcome in carriers of HBsAg. Perspectives of treatment with DNA inhibitors. (2008) (5)
- Experimental WHV infection of woodchucks: An animal model of hepadnavirus-induced liver cancer (1990) (5)
- Treatment of chronic carriers of woodchuck hepatitis virus infection with thymosin alpha-1 (1991) (5)
- The woodchuck model of hepadnavirus infection (2008) (4)
- Hepatitis B virus and primary hepatocellular carcinoma. (1983) (4)
- Immunochemistry and polypeptide composition of hepatitis B core antigen (HB/sub c/ Ag). [/sup 125/I tracer techniques] (1977) (3)
- Anti-idiotype modulation of the in vitro immune response to hepatitis B surface antigen (HBsAg) following remote infection by hepatitis B virus in man. (1989) (3)
- In vitro immune responses to hepatitis B surface antigen (pre-S2 and S) following remote infection by hepatitis B virus in humans (1989) (3)
- Cloning and characterization of partial cDNAs for woodchuck cytokines and CD3epsilon with applications for the detection of RNA expression in tissues by RT-PCR assay. (1997) (3)
- Hepatitis delta infections in Toronto, Ontario (1988) (3)
- Alpha-fetoprotein in the woodchuck model of hepadnavirus infection and disease: normal physiological patterns and responses to woodchuck hepatitis virus infection and hepatocellular carcinoma. (1990) (3)
- Experimental transmission of the delta agent to the eastern woodchuck (Marmota monax). (1983) (2)
- Antibodies to polymerized albumin in woodchuck hepatitis virus infection. (1993) (2)
- New approaches to hepatitis B vaccines. (1983) (2)
- Corrigendum to “Enhanced antiviral benefit of combination therapy with lamivudine and famciclovir against WHV replication in chronic WHV carrier woodchucks” (2000) (2)
- Sequence homology between HDV RNA and 7SL RNA: implications for pathogenesis. (1991) (2)
- Titration of recombinant woodchuck hepatitis virus DNA in adult woodchucks (1998) (2)
- Viral Pharmacodynamic Model for (–)-β-2′,3′-Dideoxy-5-Fluoro-3′-Thiacytidine (Emtricitabine) in Chronically Infected Woodchucks (2002) (2)
- Immunological characterization of hepatitis delta antigen. (1991) (1)
- Proteins ofHepatitis B Surface Antigen (1977) (1)
- The hepatitis delta virus and its infection continued. (1987) (1)
- Pharmacodynamics of (−)-β-2′,3′-Dideoxy-3′-Thiacytidine in Chronically Virus-Infected Woodchucks Compared to Its Pharmacodynamics in Humans (1998) (0)
- Demonstration of subtype (D or Y)-specific determinants on the surface of the presumed hepatitis B virus. [Radioimmunoassay] (1977) (0)
- Application of nucleic acid hybridization to the hepatitis delta virus research. (1988) (0)
- Proteins ofHepatitis B Surface Antigen: AminoAcid Compositions oftheMajorPolypeptides (1977) (0)
- Molecular Cloning ofHepatitis DeltaVirusRNA froman Infected WoodchuckLiver: Sequence, Structure, andApplications (1988) (0)
- Procede de traitement d'une infection virale par le virus de l'hepatite d (2001) (0)
- [Subpopulations and subtypes of Dane particles]. (1978) (0)
- Failure To Detect Polyalbumin-Binding Sites on the Hepatitis Virus Surface Antigen : Implications for the of Hepatitis B Virus in Humans Woodchuck Pathogenesis (0)
- Proteins of hepatitis B surface antigen. [Polypeptide content] (1977) (0)
- Patents And literature (1985) (0)
- Establishment of the joint AEC-NIH satellite laboratory at Bethesda, Maryland. ORNL-4419. (1969) (0)
- Hepatocarcinogenicity of the woodchuck hepatitis virus (hepatocellular carcinoma/precursor lesions/woodchuck hepatitis surface antigen/necroinflammation) (2016) (0)
- Molecular state of hdv and whv nucleic acids in tissues of hdv infected chronic whv carrier woodchucks (1988) (0)
- Oligonucleotides antisens contre la replication virale de l'hepatite b (1995) (0)
- Transmission of the hepatitis B virus-associated 6 agent to the eastern woodchuck ( chronic viral hepatitis / animal model / hepadnavirus ) (0)
- Contents Vol. 45, 2002 (2003) (0)
- Propagation of Rhinovirus on WI-38 Cell Monolayers in Rolling Bottles (1967) (0)
- Natura1 History of Acute Hepatitis B Surface Antigen-Positive Hepatitis in (1987) (0)
- The hepatitis delta virus. Proceedings of the Third International Symposium on Hepatitis Delta Virus. Washington, D.C., October 26-28, 1989. (1990) (0)
- Subject Index Vol. 45, 2002 (2003) (0)
- To the editor (0)
- THE CHEMICAL NATURE OF ANTIVIRAL SEROTYPE SPECIFICITY (1983) (0)
- Expression of the hepatitis B virus surface antigen gene in cell culture by using a simian virus 40 vector (recombinant DNA/animal virus/gene expression/antigen characterization) (2016) (0)
- The Hepatitis delta virus and its infection : proceedings of an international symposium on hepatitis delta virus held in Saint Vincent, Italy, June 19 to 20, 1986 (1987) (0)
- 10 HBV-DNA markers predictive of response to lamivudine (LAM) therapy in patients with hepatitis B e antigen (HBeAg)-negative chronic hepatitis B (2003) (0)
- Human Immunodeficiency Virus and Hepatitis Delta Virus in Homosexual Men (2020) (0)
- A radioimmunoassay for HBcAg in the sera of HBsAg carriers: serum HBcAg, liver HBcAg immunofluorescence as markers of chronic liver disease. (1981) (0)
- Application Of Nucleic acid hybridization to the hepatitis δ virus research (1988) (0)
- Alternative sources of hepatitis B vaccine. (1983) (0)
- Delta Virus Infection and Severe Hepatitis (2020) (0)
- Treatment of viral hepatitis (1992) (0)
- Replication and pathology of hepatitis delta virus in tobacco plants (Nicotiana sylvestris): a negative report. (1987) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With J. Wai-kuoshihandjohn L. Gerin?
J. Wai-kuoshihandjohn L. Gerin is affiliated with the following schools:
